Clinical Trial Update: a Clinical Research of Sequential CAR-T Bridging HSCT in the Treatment of Relapse/Refractory B-cell Malignancies [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating sequential CAR-T cell therapy followed by hematopoietic stem cell transplantation for relapse/refractory B-cell malig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• CAR-T cell therapy

Snippet

Sponsor: Southwest Hospital, China | Conditions: Lymphoma, Large B-Cell, Diffuse, Leukemia, Lymphocytic, Chronic, B-Cell | Phase 2 | Status: UNKNOWN